Literature DB >> 11752419

Progress in transthyretin fibrillogenesis research strengthens the amyloid hypothesis.

A Chakrabartty1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11752419      PMCID： PMC64929          DOI： 10.1073/pnas.261596398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  37 in total

1.  Amyloid fibrils from muscle myoglobin.

Authors:  M Fändrich; M A Fletcher; C M Dobson
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

Review 2.  Review: history of the amyloid fibril.

Authors:  J D Sipe; A S Cohen
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

3.  All or none fibrillogenesis of a prion peptide.

Authors:  W Q Zou; D S Yang; P E Fraser; N R Cashman; A Chakrabartty
Journal:  Eur J Biochem       Date:  2001-09

4.  An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.

Authors:  X Jiang; C S Smith; H M Petrassi; P Hammarström; J T White; J C Sacchettini; J W Kelly
Journal:  Biochemistry       Date:  2001-09-25       Impact factor: 3.162

5.  Amyloid fibril formation by a helical cytochrome.

Authors:  T A Pertinhez; M Bouchard; E J Tomlinson; R Wain; S J Ferguson; C M Dobson; L J Smith
Journal:  FEBS Lett       Date:  2001-04-27       Impact factor: 4.124

6.  Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.

Authors:  M P Sebastião; V Lamzin; M J Saraiva; A M Damas
Journal:  J Mol Biol       Date:  2001-03-02       Impact factor: 5.469

7.  Transthyretin slowly exchanges subunits under physiological conditions: A convenient chromatographic method to study subunit exchange in oligomeric proteins.

Authors:  F Schneider; P Hammarström; J W Kelly
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

8.  Trans-suppression of misfolding in an amyloid disease.

Authors:  P Hammarström; F Schneider; J W Kelly
Journal:  Science       Date:  2001-09-28       Impact factor: 47.728

9.  A glimpse of a possible amyloidogenic intermediate of transthyretin.

Authors:  K Liu; H S Cho; H A Lashuel; J W Kelly; D E Wemmer
Journal:  Nat Struct Biol       Date:  2000-09

Review 10.  Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

Authors:  M J Saraiva
Journal:  Hum Mutat       Date:  2001-06       Impact factor: 4.878
View more
  1 in total

1.  Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.

Authors:  Natalie J Galant; Antoinette Bugyei-Twum; Rishi Rakhit; Patrick Walsh; Simon Sharpe; Pharhad Eli Arslan; Per Westermark; Jeffrey N Higaki; Ronald Torres; José Tapia; Avijit Chakrabartty
Journal:  Sci Rep       Date:  2016-04-28       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.